Company Report
Last edited a month ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#48
Performance (55m)
-4.4% pa
Followed by
27
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#ASX Announcements
Added a month ago

Once loved, now, love-to-hate SM favourite Alcidion (ALC) announced a contract win to market today.

High level points are as follows:

  • Alcidion has signed a contract with Northern Adelaide Local Health Network (NALHN), a portfolio of the South Australian Department for Health and Wellbeing, for use of its Miya Precision and mobile clinical task management solutions.
  • The deployment of Miya Precision will support real-time patient flow management; command centre operations; secure clinical task management and messaging; and mobile access to realtime data
  • The Total Contract Value (TCV) is $4.5M over a five year period, structured as an initial two-year commitment with rights to extend out to five years.
  • The contract was awarded following a competitive tender process and is Alcidion’s first deployment of Miya Precision into South Australia. 


Yes it's a win.

No it's not going to knock your socks off, but is does help the company inch closer to EDBITA-breakeven for FY2025 which is what they are targeting and have announced.

Still lots of trust to repair here which is likely going to take longer than the coming 12 months unless they knock my pants off with some large-scale contract wins in the NHS - to which this is not...

Takeover target IMO. Market likes today's announcement, up about 7% at time of writing, on lower volume.

Held IRL and here (unfortunately). Probably fairly priced at these levels, which is why I hold, but looking to exit on some better news.

#FY24 Results and Report
Added 4 months ago

Alcidion (ALC) reported this morning, and I did think this one would've made it onto SM by now given the following - that bloody firehose is almost about to be turned off.

There's a bit to digest with this one.

For those that want a quick glance, highlights are as follows:

  • FY24 revenue of $37.1M and Underlying EBITDA loss of ($3.4M);
  • H2 Underlying EBITDA loss of ($0.6M), assisted by reduced staff costs in H2
  • Q2/Q3 reset of cost base now delivering annualised cost savings of $6.4M
  • FY24 operating cash outflow of ($7.1M), with a H2 positive operating cashflow of $4.3M
  • FY24 new sales of $35.3M, with $6.2M recognised in FY24
  • Milestone new contracts and extensions further validating Alcidion’s long term value proposition
  • As of August 2024, $28.0M of contracted and renewal revenue able to be recognised in FY25, excluding any revenue contribution from North Cumbria contract once finalised
  • Run-rate EBITDA breakeven at ~$36M1 of revenue; targeting EBITDA positive in FY25
  • Continued increase in market activity with opportunities progressing into the selection stage of the procurement cycle
  • ~$130M of contract and renewal revenue able to be recognised from FY25 to FY29, excluding upside expansion from existing contracts or impact of North Cumbria contract
  • Cash balance of $11.8m and no debt as of 30 June 2024


Media Release can be found here, for those that like big text and numbers (like me) - preso is here.

Biggest surprise is Revenue has reversed about 8%, largely attributed to a reduction in Capital Licenses and Product implementation. This probably also explains why Gross Margins are up (marginally) - they had to put one positive on the Exec summary.

Good to see Operating Cash Flow positive for H2 (FY24), however, doesn't appear this is sustainable, yet...

We knew costs had blown out prior to contract wins - appears they've addressed this: "Responding to the delays in customer procurement cycles, we reduced the cost base resulting in approximately $6.4m of annualised cost being removed in late Q2 and Q3. The reduced cost base, combined with winning new contracts, resulted in a material improvement to our cashflow in Q4 with the reduced Q4 cost base expected to be maintained heading into FY25."

I'm going to jump to the juicy stuff (IMO) and lets take a look at the outlook. There is (already) $28m contracted and renewal revenue able to be recognised in FY25, this does have a few assumptions baked in regarding current and newly issued contracts. Based on current cost run rate for the end of FY24, the EBITDA breakeven is $36m of revenue - which they appear to be expecting.

Would love for them to be targeting to be cashflow positive, but there is some trust to win back here, so maybe that's why the bar is a little lower.

They've also wet your appetite by advising market activity is increasing, which may also explain their 10% increase in marketing spend.

Takes a bit more to build my confidence and trust back with ALC, so I'm hoping to see some more contract wins and extensions in the near term (3-6 months). If they do get some of these coming through and pick up in H2 next year then who knows, maybe they will exceed expectations, which at present are quite low.

Held.

#Trading Halt
stale
Added 3 years ago

Alcidion has gone into a Trading Halt pending the release of an announcement regarding an acquisition and cap raise.

Announcement can be found here.


Interested to see what the offer price is and whether it'll be open for us minnows.